BCM
STIM icon

Bridgeway Capital Management’s Neuronetics STIM Stock Holding History

Bridgeway Capital Management’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$124K Hold
95,205
– – ﹤0.01% 1128
2026
Q1 		$138K Hold
95,205
– – ﹤0.01% 1089
2025
Q4 		$131K Buy
95,205
+25,000
+36% +$52.3K ﹤0.01% 1091
2025
Q3 		$192K Hold
70,205
– – ﹤0.01% 1022
2025
Q2 		$245K Buy
70,205
+25,000
+55% +$98.7K 0.01% 918
2025
Q1 		$166K Hold
45,205
– – ﹤0.01% 957
2024
Q4 		$72.8K Sell
45,205
-2,800
-6% -$2.91K ﹤0.01% 1139
2024
Q3 		$36.5K Sell
48,005
-35,000
-42% -$45.9K ﹤0.01% 1230
2024
Q2 		$149K Hold
83,005
– – ﹤0.01% 1111
2024
Q1 		$395K Buy
83,005
+20,000
+32% +$70.3K 0.01% 985
2023
Q4 		$183K Sell
63,005
-25,000
-28% -$39.4K ﹤0.01% 1151
2023
Q3 		$119K Buy
88,005
+25,000
+40% +$43.8K ﹤0.01% 1195
2023
Q2 		$135K Sell
63,005
-80,000
-56% -$194K ﹤0.01% 1209
2023
Q1 		$416K Buy
143,005
+21,949
+18% +$111K 0.01% 926
2022
Q4 		$832K Sell
121,056
-44,900
-27% -$212K 0.02% 776
2022
Q3 		$528K Buy
165,956
+87,951
+113% +$320K 0.01% 884
2022
Q2 		$250K Sell
78,005
-25,000
-24% -$72.6K 0.01% 1043
2022
Q1 		$312K Sell
103,005
-75,074
-42% -$254K 0.01% 1067
2021
Q4 		$794K Buy
178,079
+150,074
+536% +$735K 0.01% 836
2021
Q3 		$184K Sell
28,005
-240,900
-90% -$2.31M ﹤0.01% 1208
2021
Q2 		$4.31M Buy
268,905
+14,405
+6% +$199K 0.08% 357
2021
Q1 		$3.15M Sell
254,500
-18,800
-7% -$288K 0.06% 428
2020
Q4 		$3.04M Buy
273,300
+144,900
+113% +$1.09M 0.06% 367
2020
Q3 		$624K Sell
128,400
-127,800
-50% -$485K 0.01% 816
2020
Q2 		$494K Buy
256,200
+155,600
+155% +$319K 0.01% 860
2020
Q1 		$190K Sell
100,600
-24,900
-20% -$77.8K ﹤0.01% 1074
2019
Q4 		$564K Buy
125,500
+35,200
+39% +$219K 0.01% 926
2019
Q3 		$750K Buy
+90,300
New +$987K 0.01% 808

Other funds holding STIM

MAM
Madryn Asset Management New York $36.9M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bridgeway Capital Management's STIM Position: Q2 2026 in Review

Bridgeway Capital Management held its Neuronetics (STIM) position steady in Q2 2026 at 95,205 shares worth $124K. The position accounts for ﹤0.01% of the portfolio, ranked #1128.

Bridgeway Capital Management first reported a position in STIM in Q3 2019 and has held it in 28 quarters since. The position peaked at $4.31M in Q2 2021. 87 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • Bridgeway Capital Management held 95,205 shares of Neuronetics worth $124K as of Q2 2026.
  • Bridgeway Capital Management left its Neuronetics share count unchanged in Q2 2026.
  • Neuronetics made up ﹤0.01% of Bridgeway Capital Management's portfolio in Q2 2026, its #1128 holding.
  • Bridgeway Capital Management first reported a position in Neuronetics in Q3 2019 and has held it in 28 quarters since.
  • Bridgeway Capital Management's Neuronetics position peaked at $4.31M in Q2 2021.
  • 87 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.